PharmaCyte Biotech, Inc. (PMCB) stock
PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
$0.40+0.00 (+0.75%)
Close on Nov 12, 2026Market cap $4.32MP/E –Yield –
PharmaCyte Biotech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
PharmaCyte Biotech's enterprise value was -$13.55M on Nov 11, 2026, against -$10.28M a year earlier. Over the last 5 years it ranged from -$56.23M to -$8.12M, with a median of -$19.47M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$13.55M | – |
| 2025 | Dec 31, 2025 | -$10.30M | – |
| 2024 | Dec 31, 2024 | -$9.80M | – |
| 2023 | Dec 29, 2023 | -$54.63M | – |
| 2022 | Dec 30, 2022 | -$19.75M | – |
| 2021 | Dec 31, 2021 | -$35.15M | -382.4% |
| 2020 | Dec 31, 2020 | $12.45M | -77.7% |
| 2019 | Dec 31, 2019 | $55.69M | +37.7% |
| 2018 | Dec 31, 2018 | $40.44M | -24.3% |
| 2017 | Dec 29, 2017 | $53.43M | -58.6% |
| 2016 | Dec 30, 2016 | $129.10M | +288.7% |
| 2015 | Dec 31, 2015 | $33.22M | -74.1% |
| 2014 | Dec 31, 2014 | $128.32M | +108.2% |
| 2013 | Dec 31, 2013 | $61.62M | – |
See a number that looks wrong?